Synthetic Biology in Agriculture Market Highlights

• The global synthetic biology in agriculture market is projected to reach USD 71.9 billion by 2032, with a CAGR of 36.9% from 2024 to 2032
• In 2023, the North American market held a value of approximately USD 1.68 billion
• The Asia-Pacific region is expected to grow at a CAGR of over 38% from 2024 to 2032
• Rising investments and government support for research in agricultural biotechnology is the market trend that fuels the industry demand

Synthetic biology in agriculture involves applying advanced genetic engineering and biotechnology techniques to modify crops and agricultural processes for improved productivity, sustainability, and efficiency. It enables the development of genetically enhanced crops with traits like pest resistance, drought tolerance, and higher yields. Synthetic biology also facilitates the creation of bio-based fertilizers, eco-friendly pesticides, and innovations in soil management. This field aims to revolutionize traditional agriculture, addressing global challenges like food security and environmental sustainability.

Global Synthetic Biology in Agriculture Market Dynamics

Market Drivers

• Increasing demand for sustainable agricultural practices
• Advances in genetic engineering and biotechnology
• Growing need for efficient crop production and pest control

Market Restraints

• Regulatory challenges and policy uncertainties
• High initial investment and research costs
• Public concerns over safety and environmental impact

Market Opportunities

• Development of genetically modified crops with higher yields
• Innovation in bio-based fertilizers and pesticides
• Expansion of synthetic biology applications in climate-resilient agriculture

Synthetic Biology in Agriculture Market Report Coverage

Synthetic Biology in Agriculture Market Insights

As global food demand rises, there is growing need to implement more sustainable farming practices. According to the World Bank, food demand is anticipated to rise anywhere from 59% to 98% by 2050. While Big Food companies like General Mills and Unilever have enormous global influence over what people eat, trading companies have a much greater impact on food security because they source and distribute staple foods and ingredients used by big food, such as rice, wheat, corn, sugar, soybeans, and oil palm. This growing demand further enhances industry’s growth.

Breakthroughs in genetic engineering and biotechnology have made it easier to modify crops at a molecular level. For instance, Future of Biotech states that by 2040, biotechnology is expected to greatly improve many areas of human life. Automation and the use of data are becoming more common in biotechnology, which will help make research and manufacturing results more predictable and consistent. Additionally, U.S. Department of Agriculture states that some biotechnology crops can be bred to tolerate certain herbicides, making weed management easier and more effective. Such innovations contribute to improving agricultural productivity and ensuring food security.

The development and commercialization of synthetic biology applications in agriculture require significant investment in research and development. These high upfront costs can limit access for smaller companies and farmers.

Development of genetically modified crops with higher yields becomes opportunity for industry in forecast year. For instance, on July 23, the Supreme Court of India directed the government to develop a national policy on genetically modified (GM) crops, including research, farming, trade, and commerce, after consultation with the people. By setting clear guidelines for research, farming, trade, and commerce, the policy would create a more structured and regulated environment for GM crop development which enhance industry growth.

Synthetic Biology in Agriculture Market Segmentation

The worldwide market for synthetic biology in agriculture is split based on technology, crop type, application, and geography.

By Technology

• Synthetic Biology Platforms
• Metabolic Engineering
• Genome Sequencing
• Gene Editing
• Other Technologies

As per technology, gene editing technology, particularly CRISPR-Cas9, dominates market due to its precision and efficiency in altering the genetic makeup of crops. This technology allows for targeted modifications, enhancing desirable traits like pest resistance, drought tolerance, and improved nutritional content. Unlike traditional genetic modification methods, gene editing can introduce specific changes without the need for foreign DNA, making it more acceptable in various regulatory environments. Its ability to accelerate crop improvement and reduce development timelines makes gene editing a key driver of innovation in agriculture.

By Crop Type

• Oilseeds and Legumes
• Fruits and Vegetables
• Cereals and Grains
• Other Crops

The cereals and grains category is expected to experience significant growth in market due to the rising global demand for food and the need to enhance crop yields. Genetic modifications enabled by synthetic biology can improve the resilience of crops like wheat, rice, and corn, making them more resistant to pests, diseases, and environmental stressors. With climate change affecting crop productivity, these innovations offer solutions for more sustainable and higher-yielding crops. Additionally, genetically enhanced cereals and grains can contribute to improving global food security and meeting the nutritional needs of a growing population.

By Application

• Livestock Improvement
• Food Additives and Ingredients
• Crop Yield Improvement
• Crop Protection
• Other Applications

According to application, the crop protection segment is rapidly growing in business as it offers innovative solutions for combating pests, diseases, and weeds. Synthetic biology enables the development of bio-based pesticides and pest-resistant crops, reducing the reliance on chemical treatments. This approach is more sustainable, minimizes environmental damage, and addresses concerns about pesticide resistance. With the increasing demand for eco-friendly and effective crop protection methods, synthetic biology is poised to revolutionize this sector.

Synthetic Biology in Agriculture Market Regional Outlook

North America

• U.S.
• Canada

Europe

• U.K.
• Germany
• France
• Spain
• Rest of Europe

Asia-Pacific

• India
• Japan
• China
• Australia
• South Korea
• Rest of Asia-Pacific

Latin America

• Brazil
• Mexico
• Rest of Latin America

The Middle East & Africa

• South Africa
• GCC Countries
• Rest of the Middle East & Africa (ME&A)

Synthetic Biology in Agriculture Market Regional Analysis

For several reasons, North America dominates the market because to its robust R&D infrastructure and favorable regulatory environment. Government assistance for sustainable farming practices helps to boost the region's market position. For example, the Natural Resources Conservation Service directs the United States Department of Agriculture's Office of Urban Agriculture and Innovative Production, which invested $7.4 million in grants and $9.4 million in cooperative agreements in 2023. This financing promotes sustainable farming methods, and environmental conservation.

The Asia-Pacific region is experiencing rapid growth in market, driven by the need to boost agricultural productivity and food security. With a large agricultural base and increasing population, countries like China and India are investing in biotechnology to improve crop yields and pest resistance. For instance, as per India Brand Equity Foundation (IBEF), the Department of Biotechnology (DBT), which is part of the Ministry of Science and Technology, has prioritized the establishment of an ecosystem for excellence and research in a wide range of biotechnology sectors in India. As of 2022, there are an estimated 6,756 biotechnology startups. By 2025, India is predicted to have 10,000 startups. Additionally, the region’s adoption of advanced agricultural technologies is accelerating market expansion.

Synthetic Biology in Agriculture Market Players

Some of the top synthetic biology in agriculture companies offered in our report include Genentech, Roche, Amgen, Biogen, Pfizer, Regeneron Pharmaceuticals, Abiomed, BioMarin Pharmaceutical, Novartis, Incyte, Sanofi, and Celgene.